Aditya Agarwala, an analyst from Invest4edu, shared his insights on two stocks that have captured the attention of traders and investors alike, Shree Cement and Alembic Pharma Ltd.

Share Market Live

NSE

Shree Cement, a prominent player in the cement industry, is currently garnering attention for its technical chart setup. Aditya Agarwala pointed out that the stock is showing promising signs, saying, "Shree Cement is looking very interesting on the charts. It's on the verge of a breakout from a neckline of an inverted head and shoulders pattern. So that's a bullish setup." This pattern indicates a potential upward trend in the stock's price.

At current levels, Agarwala recommends going long on Shree Cement, with a target price of Rs 28,500 on the upside. He advises setting a stop loss at Rs 26,100 to manage risk effectively. This setup not only offers an attractive potential gain but also presents a favorable risk-to-reward ratio for investors.

Over the past month, Shree Cement's shares have already gained more than 2.

Alembic Pharma Limited, a key player in the pharmaceutical sector, is also turning heads for its recent market performance. Agarwala highlighted that the stock has entered into a sideways consolidation phase and is now breaking out from this pattern. "All the pharma space has been doing well, and Alembic has been one of those top gainers," noted Agarwala.

For those looking to capitalize on Alembic Pharma's potential gains, Agarwala recommends a long position, with a target price of Rs 840 on the upside and a stop loss at Rs 750 on the downside. This trade also offers a decent risk-to-reward ratio, providing investors with an appealing opportunity to participate in the stock's upward momentum.

Over the last month, Alembic Pharma Limited has witnessed a substantial increase in its share price, surging more than 3%.

For more details, watch accompanying video